Evidence map›Paper›PMID 41051582›Full record

ArticleLasers in medical science2025

Modified YAG laser treatment of retinal artery occlusion.

Da-Guang Bi, Bo-Wen Ma, Wei-Lin Wang, Wei Zhang, Zhi-Qing Li

Abstract read
PubMed Publisher
In one paragraph

Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Da-Guang BiTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, No. 251 Fukang Road, Xiqing District, 300384, Tianjin, China.
Bo-Wen MaBeijing Aier Intech Eye Hospital, 100021, Beijing, China.
Wei-Lin WangBeijing Aier Intech Eye Hospital, 100021, Beijing, China.
Wei ZhangBeijing Aier Intech Eye Hospital, 100021, Beijing, China. 1215685618@qq.com.
Zhi-Qing LiTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, No. 251 Fukang Road, Xiqing District, 300384, Tianjin, China. drzhiqing_li@163.com.

Funding

Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-037A
6 · The paper itself

Abstract

Transluminal Nd: YAG laser embolysis (TYE) is a method for the treatment of retinal artery occlusion (RAO). The objective of this study was to improve methods and reevaluate the efficacy and safety of modified TYE (MTYE) for the treatment of RAO with visible emboli in the fundus. We included non-arteritis RAO with fundus emboli visible in patients whose onset time was less than one month and who did not respond to conventional therapy. Seventeen patients (17 eyes) received MTYE treatment, and Fluorescence Fundus Angiography (FFA) was used to determine retinal artery flow recanalization changes before and after treatment. Compared with before MTYE, BCVA after treatment improved, and the results were statistically significant. BCVA (logMAR) was significantly improved at the last examination, changing from 1.23 ± 0.75 to 0.74 ± 0.7 (p < 0.001). Reperfusion was achieved in 15 eyes (88%), which was the initial surgery for treating RAO. During the follow-up period, vitreous hemorrhage occurred in two cases and two eyes, which were completely absorbed after one month of drug treatment, and no serious adverse reactions occurred in other patients. Therefore, MTYE can be used as an effective and safe treatment for RAO patients with visible emboli in the fundus. Data Access Statement: No.

Indexed as

Embolization, TherapeuticLasers, Solid-StateRetinal Artery OcclusionAdultAgedAged, 80 and overFemaleFluorescein AngiographyFundus OculiHumansMaleMiddle AgedTreatment OutcomeVisual AcuityEfficacy and safetyModified transluminal nd:yag laser embolysis (MTYE)Retinal artery occlusion

Identifiers

PMID41051582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.